Monographie - Mitomycin

Poslední aktualizace :
19/11/2024

Mitomycin

Chemický vzorec

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Ametycine	Francie
Crisofimina	Argentina
Fatrix	Chile
Maximitom	Argentina
Maximiton	Ekvádor
Minazol	Kolumbie
Mitameta	Itálie
Mitem	NÏmecko, Švýcarsko
Mitocin	BrazÌlie
Mitokebir	Argentina, Ekvádor
Mitolem	Kolumbie, Venezuela
Mitomicina	äpanÏlsko, Argentina, Chile, Ekvádor, Itálie, Mexiko, Peru, Portugalsko, Rumunsko
Mitomycin	Belgie, Dánsko, Finsko, Írán, Irsko, Itálie, Malajsie, MaÔarsko, NÏmecko, Norsko, nový Zéland, Polsko, Rakousko, Slovinsko, Švédsko, Turecko, USA, Velká Británie, ÿecko
Mitomycine	Lucembursko, Nizozemsko
Mitotie	Argentina, Chile, Ekvádor, Peru
Mitozytrex	USA
Mixandex	Kolumbie, Mexiko
Mutamycin	USA
Riptam	Kolumbie
Ronzine	Argentina, Peru
Urocin	NÏmecko

Odkazy : Mitomycin

	typ	uveřejnění
3	noviny	Trissel LA, Martinez JF. Compatibility of amifostine with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
81	noviny	Trissel LA, Martinez JF. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1994 ; 51: 672-678.
84	noviny	Trissel LA, Martinez JF. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1994 ; 51: 495-499.
99	noviny	Trissel LA, Martinez JF. Compatibility of aztreonam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
169	noviny	Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1993 ; 50: 2359-2363.
182	noviny	Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60.
244	noviny	Trissel LA, Martinez JF. Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1907-1913.
249	noviny	Trissel LA, Martinez JF. Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
307	noviny	Trissel LA, Martinez JF. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1792-1799.
334	noviny	Trissel LA, Tramonte SM, Grilley BJ. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 988-992.
335	noviny	Trissel LA, Bready BB, Kwan JW, Santiago NM. Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection. Am J Hosp Pharm 1992 ; 49: 402-406.
407	noviny	Quebberman EJ, Hoffman NE, Ausman RK, Hamid AAR. Stability of mitomycin admixtures. Am J Hosp Pharm 1985 ; 42: 1750-1754.
485	noviny	Dorr RT, Liddil JD. Stability of mitomycin C in different infusion fluids: compatibility with heparin and glucocorticosteroids. J Oncol Pharm Practice 1995 ; 1: 19-24.
648	noviny	Das Gupta V. Stability of mitomycin aqueous solution when stored in tuberculin syringes. Int J Pharm Compound 1997 ; 1: 282-283.
835	noviny	Edwards D, Selkirk AB, Taylor RB. Determination of the stability of mitomycin C by high performance liquid chromatography. Int J Pharm 1979 ; 4: 21-26.
905	noviny	Trissel LA, Martinez JF. Screening teniposide for Y-site physical incompatibilities. Hosp Pharm 1994 ; 29: 1010-1017.
1026	noviny	Mayron D, Gennaro AR. Stability and compatibility of topotecan hydrochloride with selected drugs. Am J Health-Syst Pharm 1999 ; 56: 875-881.
1178	noviny	Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL. Stability and compatibility of antitumor agents in glass and plastic containers. Am J Hosp Pharm 1981 ; 38: 1914-1918.
1239	noviny	Stolk LML, Fruijtier A, Umans. Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use. Pharm Weekbl [Sci] 1986 ; 8: 286-288.
1410	noviny	Trissel LA, Martinez JF, Simmons M. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 141-145.
1423	noviny	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1827	noviny	Beijnen JH, Van Gijn R, Underberg WJM. Chemical stability of the antitumor mitomycin C in solutions for intravesical instillation. J Parenter Sci Technol 1990 ; 44: 332-335.
2247	noviny	Chan P, Heatherly K, Kupiec T.C, Trissel L.A. Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2008 ; 12, 3: 276-278.
3128	Laboratoř	Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit Prostrakan 2013
3575	Laboratoř	Mitomycine (Ametycine®) - Résumé des caractéristiques du produit Prostrakan 2013
3897	noviny	Briot T, Truffaut C, Le Quay L, Lebreton A, Lagarce F. Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials. Pharmaceutical Technology in Hospital Pharmacy 2016 ;1,2:83-89
4154	Laboratoř	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4282	noviny	Myers A-L, Zhang Y-P, Kawedia J-D, Zhou X,. Sobocinski S-M, Metcalfe M-J, Kramer M-A, Dinney C.P.N, Kamat A-M. Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration. Drugs R D 2017
4367	noviny	Kinast R.M, Akula K.K, DeBarber A.E, Barker G.T, Gardiner S.K, Whitson E, Mansberger S.L. The Degradation of Mitomycin C Under Various Storage Methods. J Glaucoma 2016 ; 25, 6: 477-481.
4471	Laboratoř	Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019 Kyowa Kirin Pharma 2019
4526	noviny	Nisse, Y.E, Vigneron J, Zenier H, D'Huart E, Demoré B. Stability of mitomycin in polypropylene syringes for use in glaucoma surgery. EJOP 2021 4: 1.
4763	noviny	Almasi J, Erdnuss F, Thiesen J, Krämer I. Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL) Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1

Mentions Légales